RAYMOND JAMES & ASSOCIATES - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q2 2017. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$671,000
+14.1%
163,623
-0.7%
0.00%
Q4 2021$588,000
-4.4%
164,782
-2.5%
0.00%
-100.0%
Q3 2021$615,000
-21.1%
169,001
-5.4%
0.00%0.0%
Q2 2021$779,000
-5.0%
178,566
-10.5%
0.00%0.0%
Q1 2021$820,000
+17.1%
199,413
+13.7%
0.00%0.0%
Q4 2020$700,000
+46.8%
175,340
-0.7%
0.00%0.0%
Q3 2020$477,000
-16.2%
176,594
-14.7%
0.00%0.0%
Q2 2020$569,000
+34.8%
207,018
+15.8%
0.00%0.0%
Q1 2020$422,000
-22.6%
178,770
+54.2%
0.00%0.0%
Q4 2019$545,000
+289.3%
115,909
+177.9%
0.00%
Q3 2019$140,000
+2.9%
41,705
+0.7%
0.00%
Q2 2019$136,000
+15.3%
41,416
+6.8%
0.00%
Q1 2019$118,000
+15.7%
38,793
+3.6%
0.00%
Q4 2018$102,000
+343.5%
37,449
+230.7%
0.00%
Q4 2017$23,000
-37.8%
11,3230.0%0.00%
Q3 2017$37,000
+15.6%
11,323
+12.2%
0.00%
Q2 2017$32,00010,0920.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,055,0004.58%
Centric Wealth Management 3,337,449$13,717,0003.92%
Sargent Investment Group, LLC 3,599,580$14,794,0003.90%
Rubric Capital Management LP 8,722,647$35,850,0002.09%
PERKINS CAPITAL MANAGEMENT INC 542,283$2,229,0001.29%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$7,809,0001.17%
Venator Capital Management Ltd. 550,000$2,624,0000.89%
LEVEL FOUR FINANCIAL, LLC 120,000$493,0000.23%
ALGERT GLOBAL LLC 147,616$607,0000.19%
Brown Advisory Securities, LLC 275,000$1,130,0000.19%
View complete list of ANTARES PHARMA INC shareholders